Search Indian IP Case Law
Judgments of the Supreme Court and the High Courts on patents, trade marks, copyright, designs and geographical indications — organised by Act and section, each with a link to the judgment on the court’s website.
4 results
for “Efficacy”
F. Hoffmann-La Roche Ltd. & Anr. v. Cipla Ltd.
A patent claim for a chemical compound is not to be narrowed to a specific polymorphic or crystalline form merely because the specification discusses particular polymorphs, where the claim itself is drafted broadly to cover the co…
Claim ConstructionPatent InfringementPharmaceutical PatentPolymorphPatentsIntra-Cellular Therapies, Inc. v. The Controller of Patents
Although the deuterated compound demonstrated approximately 72% higher parent-drug exposure in the blood, the comparative studies showed substantially similar pharmacological activity between the deuterated and non-deuterated comp…
Deuterated CompoundsHeterocycle-fused Gamma-carbolinesParent Drug ExposurePharmacological ActivityPatentsNovartis AG v. Union of India & Ors.
Section 3(d) of the Patents Act, 1970 imposes a distinct and higher threshold of patentability for new forms of known substances, over and above the ordinary tests of novelty and inventive step. A new form of a known substance mus…
EfficacyEvergreeningInventive StepKnown SubstancePatentsSyngenta Participations AG v. Controller of Patents and Designs
Under Section 3(d) of the Patents Act, 1970, efficacy is not a fixed, uniform standard confined to therapeutic effect; its content depends on the field of the invention. For an agrochemical compound, a new polymorphic form demonst…
EfficacyInventive StepPatent ProsecutionPrior Art